Dry skin
Conditions
Interventions
Ingestion of placebo capsules for 12 consecutive weeks
Ingestion of capsules include Lactobacillus brevis SBC8803 50mg per a day for 12 consecutive weeks
Ingestion of capsules include Lactobacillus br
Sponsors
Total Technological Consultant Co., Ltd.(TTC)
SAPPORO BREWERIES LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Males and females between the ages of 20 and 59 2. Higher level of transepidermal water loss on arm
Exclusion criteria
Exclusion criteria: 1. Subjects who have had lactobacillus-rich food, dietary supplements, or medicines constantly 2. Subjects who have used dietary supplements , medicines wchich affects skin constantly 3. Subjects who have treated cosmetic care 4. Subjects who treated cosmetic care except for measuring site or hormonal therapy 5. Subjects who got a facial, a wash-rag, lost hair, or plan these actions 6. Subjects who takes a medicine constantly 7. Subjects who plan to get a tan 8. Subjects who wash the body which provides strong skin irritation 9. Subjects who have a wound or a inflammatory disease 10. Subjects who diagnosed atopy or skin disorders 11. Subjects who have asthma or the possibility of asthma 12. Subjects who have a possibility of having hay fever and gettig a medicine, or is expecdted to develop a symptom of allergic states at the skin in the current study term 13. Subjects who feels to trouble by rough skin around a menstruates 14. Subjects who is employed on a pre-dawn shift or on night duty 15. Subjects who have diabetes, liver disease, kidney disease, or diseases wchich affects a secretion of sex hormones 16. Subjects who have participated in other clinical study 17. Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination 18. Subjects who plans to become pregnant or lactate 19. Subjects who plans to go overseas 20. Subjects who have taken a blood sample or donated blood beyond the limit rules within the last one year prior to the screening test 21. Subjects who take measures affecting the results in current study, or don't stick to the rules 22. Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 23. Subjects who are judged as unsuitable for the study by physician for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transepidermal water loss | — |
Secondary
| Measure | Time frame |
|---|---|
| Moisture content of the stratum corneum, skin conditions, questionnaire(skin, feces), Athens insomnia scale, Pittsburgh sleep quality index(Japanese) | — |
Countries
Japan
Contacts
Public ContactNAKAGAWA Takashi
Total Technological Consultant Co., Ltd.(TTC) Clinical Research Planning Dept.
Outcome results
None listed